Cargando…
Individual risk of post-ivermectin serious adverse events in subjects infected with Loa loa
BACKGROUND: Implementation of onchocerciasis elimination programmes has been delayed in Central Africa because of the risk of ivermectin-related serious adverse events (SAEs) in individuals with high Loa loa microfilarial densities (MFD). We developed the first statistical models enabling prediction...
Autores principales: | Chesnais, Cédric B., Pion, Sébastien D., Boullé, Charlotte, Gardon, Jacques, Gardon-Wendel, Nathalie, Fokom-Domgue, Joël, Kamgno, Joseph, Boussinesq, Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700892/ https://www.ncbi.nlm.nih.gov/pubmed/33294807 http://dx.doi.org/10.1016/j.eclinm.2020.100582 |
Ejemplares similares
-
Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon
por: Boussinesq, Michel, et al.
Publicado: (2003) -
Effect of a Single Standard Dose (150–200 μg/kg) of Ivermectin on Loa loa Microfilaremia: Systematic Review and Meta-analysis
por: Pion, Sébastien D, et al.
Publicado: (2019) -
Temporal variability of Loa loa microfilaraemia
por: Campillo, Jérémy T., et al.
Publicado: (2023) -
Factors associated with the periodicity of Loa loa microfilaremia in the Republic of the Congo
por: Campillo, Jérémy T., et al.
Publicado: (2022) -
Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control
por: Thomson, Madeleine C, et al.
Publicado: (2004)